ArticleCell death & disease2022

Correction: The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression.

Yangyang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.